Inhibition of AURKA destabilizes glioblastoma primary cilia and sensitizes cells to tumor treating fields (TTFields) in vitro and ex vivo

被引:0
|
作者
Tian, Jia
Mallinger, Julianne
Shi, Ping
Ling, Dahao
Deleyrolle, Loic
Lin, Min
Khoshbouei, Habibeh
Sarkisian, Matthew
机构
关键词
D O I
10.1158/1538-7445.AM2023-5961
中图分类号
R73 [肿瘤学];
学科分类号
100214 ;
摘要
5961
引用
收藏
页数:2
相关论文
共 50 条
  • [1] Effects of tumor treating fields (TTFields) on glioblastoma cells are augmented by mitotic checkpoint inhibition
    Almuth F. Kessler
    Greta E. Frömbling
    Franziska Gross
    Mirja Hahn
    Wilfrid Dzokou
    Ralf-Ingo Ernestus
    Mario Löhr
    Carsten Hagemann
    Cell Death Discovery, 4
  • [2] Effects of tumor treating fields (TTFields) on glioblastoma cells are augmented by mitotic checkpoint inhibition
    Kessler, Almuth F.
    Froembling, Greta E.
    Gross, Franziska
    Hahn, Mirja
    Dzokou, Wilfrid
    Ernestus, Ralf-Ingo
    Loehr, Mario
    Hagemann, Carsten
    CELL DEATH DISCOVERY, 2018, 4
  • [3] Inhibition of PI3-Kinase sensitizes cancer cells to Tumor Treating Fields (TTFields)
    Klein-Goldberg, Anat
    Seitz, Stefanie
    Antonietti, Patrick
    Voloshin, Tali
    Zemer-Tov, Efrat
    Paz, Rom
    Koren, Lilach
    Wainer-Katsir, Kerem
    Volodin, Alexandra
    Koltun, Bella
    Brant, Boris
    Barsheshet, Yiftah
    Kan, Tal
    David, Cfir
    Khalil, Tharwat Haj
    Haber, Adi
    Giladi, Moshe
    Weinberg, Uri
    Palti, Yoram
    STRAHLENTHERAPIE UND ONKOLOGIE, 2023, 199 : S161 - S161
  • [4] GLIOBLASTOMA CELLS FROM A PATIENT POST-TUMOR TREATING FIELDS (TTFIELDS) THERAPY ARE SENSITIVE TO TTFIELDS IN VITRO
    Michelhaugh, Sharon K.
    Kiousis, Sam
    Mittal, Sandeep
    NEURO-ONCOLOGY, 2017, 19 : 87 - 87
  • [5] Disrupting glioblastoma networks with tumor treating fields (TTFields) in in vitro models
    Schlieper-Scherf, Steffen
    Hebach, Nils
    Hausmann, David
    Azorin, Daniel D.
    Hoffmann, Dirk C.
    Horschitz, Sandra
    Maier, Elena
    Koch, Phillip
    Karreman, Matthia A.
    Etminan, Nima
    Ratliff, Miriam
    JOURNAL OF NEURO-ONCOLOGY, 2024, 170 (01) : 139 - 151
  • [6] Tumor-treating fields (TTFields) effects on glioblastoma cells are augmented by mitotic checkpoint inhibition
    Kessler, Almuth F.
    Froembling, Greta E.
    Gross, Franziska
    Hahn, Mirja
    Dzokou, Wilfrid
    Ernestus, Ralf-Ingo
    Loehr, Mario
    Hagemann, Carsten
    CANCER RESEARCH, 2018, 78 (13)
  • [7] A FGFR1 INHIBITION SENSITIZES GLIOBLASTOMA STEM CELLS TO TUMOR TREATING FIELDS
    Gouaze-Andersson, V
    Deshors, P.
    Cohen-Jonathan Moyal, E.
    NEURO-ONCOLOGY, 2024, 26
  • [8] Glioblastoma-Derived Three-Dimensional Ex Vivo Models to Evaluate Effects and Efficacy of Tumor Treating Fields (TTFields)
    Nickl, Vera
    Schulz, Ellina
    Salvador, Ellaine
    Trautmann, Laureen
    Diener, Leopold
    Kessler, Almuth F.
    Monoranu, Camelia M.
    Dehghani, Faramarz
    Ernestus, Ralf-Ingo
    Loehr, Mario
    Hagemann, Carsten
    CANCERS, 2022, 14 (21)
  • [9] Concomitant application of temozolomide, Tumor Treating Fields (TTFields), and lomustine in glioblastoma cells in vitro indicates better efficacy
    Fishman, H.
    Monin, R.
    Dor-On, E.
    Haber, A.
    Ehrle, S.
    Giladi, M.
    Weinberg, U.
    Palti, Y.
    STRAHLENTHERAPIE UND ONKOLOGIE, 2022, 198 (SUPPL 1) : S79 - S79
  • [10] Tumor Treating Fields (TTFields) Concomitant with Sorafenib Inhibit Hepatocellular Carcinoma In Vitro and In Vivo
    Davidi, Shiri
    Jacobovitch, Sara
    Shteingauz, Anna
    Martinez-Conde, Antonia
    Braten, Ori
    Tempel-Brami, Catherine
    Zeevi, Einav
    Frechtel-Gerzi, Roni
    Ene, Hila
    Dor-On, Eyal
    Voloshin, Tali
    Tzchori, Itai
    Haber, Adi
    Giladi, Moshe
    Kinzel, Adrian
    Weinberg, Uri
    Palti, Yoram
    CANCERS, 2022, 14 (12)